Sunil Badve's Publications

About Sunil Badve's Publications

Program Lead, Cardiometabolic Trials, Renal and Metabolic Program

  • Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results

    Journal of the American Society of Nephrology Date published:

  • Variability in eGFR and Adverse Kidney Outcomes in Routine Clinical Practice

    Journal of the American Society of Nephrology Date published:

  • Sex-Related Differences in CKD Monitoring and Cardiovascular Risk Management in Australian Primary Care: A Retrospective Cohort Study

    Journal of the American Society of Nephrology Date published:

  • Effect of Semaglutide on Kidney Outcomes: Pooled Analysis of the SELECT, FLOW, and SOUL Trials

    Journal of the American Society of Nephrology Date published:

  • Quality of care for people with chronic kidney disease: a systematic review and meta-analysis

    BMJ Open Date published:

  • Prevalence of SGLT2 inhibitor and GLP1 receptor agonist prescriptions in type 2 diabetes patients with and without chronic kidney disease: Analysis of an Australian primary care dataset

    Diabetes, Obesity and Metabolism Date published:

  • Albuminuria, Kidney Function and Heart Failure Risk in Type 2 Diabetes: Participant-level pooled analysis from CANVAS Program and CREDENCE trial

    Journal of Cardiac Failure Date published:

  • Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression

    Clinical Journal of the American Society of Nephrology Date published:

  • Glomerular disease registry and biobank: design and baseline results

    Internal Medicine Journal Date published:

  • Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation

    Kidney360 Date published:

  • Assessing patterns of chronic kidney disease care in Australian primary care: a retrospective cohort study of a national general practice dataset

    The Lancet Regional Health - Western Pacific Date published:

  • Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD

    Kidney International Reports Date published:

  • Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials

    Diabetes Care Date published:

  • Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease

    Nephrology Dialysis Transplantation Date published:

  • The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

    Kidney International Date published:

  • Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials

    The Lancet Diabetes & Endocrinology Date published: